TA Associates has made a strategic growth investment in 40-year-old Indian business Synokem Pharmaceuticals. The post TA Associates eyes global expansion of 40-year-old Indian pharma business Synokem first appeared on AltAssets Private Equity News.
Global investment giant Ardian has reinvested in Italian pharmaceutical commercialisation business Neopharmed. The post Ardian reinvests in Italian pharma business Neopharmed, NB Renaissance joins as investor first appeared on AltAssets Private Equity News.
European healthcare investor GHO Capital Partners has teamed with Vistria Group to buy a controlling stake in pharma contract development and manufacturing organization Alcami. The post Madison Dearborn, Ampersand sell Alcami stake to GHO Capital,
Chicago-based buyout house Core Industrial Partners has sold pharma packaging and labelling specialist MedLit Solutions to trade buyer Resource Label Group. The post Core Industrial Partners seals rapid MedLit solutions trade sale after just two years
DW Healthcare Partners has sold veterinary pharma specialist Med-Pharmex to trade buyer Dechra Pharmaceuticals after almost a decade in its portfolio. The post After almost a decade of ownership, DW Healthcare seals Med-Pharmex trade sale
NovaQuest Capital Management has struck a $500m hard cap close for its latest private equity investment fund. The post NovaQuest strikes $500m hard cap for latest life science, pharma services-focused private equity fund first appeared
French private equity group Astorg has agreed a buyout of drug contract development and manufacturing business CordenPharma in a deal reportedly worth more than €2.5bn. The post Astorg agrees CordenPharma carve-out in deal said to exceed
European buyout house Inflexion Private Equity has made what it calls a "substantial" investment into UK specialist contract development and manufacturing organisation Upperton Pharma Solutions. The post Inflexion buys into pharma industry particle engineering specialist Upperton
US private equity house Genstar Capital is reportedly hoping to reach a $5bn price tag for pharmaceuticals and regulatory consulting business Advarra through a potential sale. The post Genstar Capital said to eye over $5bn
European private equity house Montagu has entered exclusive negotiations with Bridgepoint to acquire HTL Biotechnology, a fast-growing biotech and industrial business specialising in pharmaceutical grade biopolymers. The post Bridgepoint sells fast-growing biotech business HTL to Montagu
A string of private equity giants including Blackstone and Carlyle are reportedly circling GlaxoSmithKline’s consumer unit in a deal which could see it valued at up to £40bn. The post Buyout giants eye mammoth $54bn
Private equity pair Nordic Capital and Avista Capital Partners has agreed to sell Swiss pharma business Acino to Abu Dhabi sovereign wealth investor ADQ. The post Abu Dhabi sovereign arm buys Nordic Capital, Avista-backed pharma
Buyout house Astorg and Goldman Sachs Asset Management have received a binding €1.8bn offer for HRA Pharma from trade buyer Perrigo. The post Astorg, Goldman Sachs AM get €1.8bn binding offer for HRA Pharma first
US private equity major GTCR's Antylia Scientific portfolio company has agreed to sell its Masterflex business unit to Avantor for $2.9bn in an all-cash transaction. The post GTCR to sell Antylia Scientific’s Masterflex unit in
Warburg Pincus-backed Insilico Medicine is reportedly prepping for an IPO which could see it raise up to $300m. The post Insilico said to prep IPO, just a month after Warburg Pincus backing first appeared on
Private equity major BC Partners has scored what is believed to be a 4x return through the €1.6bn sale of European generic drugmaker Pharmathen to Partners Group. The post BC Partners believed to score 4x
An estimated 25% of global drug production is in the hands of little-known players CDMOs, making them indispensable for industry, global healthcare systems and patients - not least during Covid. Navigating this terrain is tricky,
Specialist private equity investor Adragos Pharma has brought in serial-entrepreneur and large family office head Otto Prange as general partner and investment committee chair.
Private equity major Nordic Capital has offered to buy complex medicines specialist Advanz Pharma in an $846m deal.
Private equity house EQT has agreed a $2.1bn take-private deal for Swedish pharmaceutical business Recipharm.
